Trial Profile
Efficacy and Safty of Long Acting Beraprost (TRK-100STP) for Lumbar Spinal Canal Stenosis with Intermittent Claudication :A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 02 Jan 2010
Price :
$35
*
At a glance
- Drugs Beraprost (Primary)
- Indications Embolism and thrombosis; Intermittent claudication
- Focus Adverse reactions; Therapeutic Use
- 02 Jan 2010 New trial record